Dolly Vance | Executive Vice President, Corporate Affairs and General Counsel |
Raul Rodriguez | President and Chief Executive Officer |
Dave Santos | Executive Vice President and Chief Commercial Officer |
Wolfgang Dummer | Executive Vice President and Chief Medical Officer |
Dean Schorno | Executive Vice President and Chief Financial Officer |
Jorge Cortes | Director, Georgia Cancer Center. Augusta University |
Eun Yang | Jefferies |
Joe Pantginis | H.C. Wainwright |
Gary Nachman | BMO Capital Markets |
Kalpit Patel | B. Riley Securities |
Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Second Quarter 2022. At this time, all participants are in a listen-only-mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel.